Showing results (21-30 of 197) with videos related to

Sort By:
Pageof 20
Nephrology (Carlton, Vic.)|October 18, 2013
Anti-coagulation, anti-platelets or no therapy in haemodialysis patients with atrial fibrillation: A decision analysisMelanie Lr Wyld, Philip A Clayton, Rachael L Morton, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 24, 2022
Estimating loss in capability wellbeing in the first year of the COVID-19 pandemic: a cross-sectional study of the general adult population in the UK, Australia and the NetherlandsPaul Mark Mitchell, Rachael L Morton, Mickaël Hiligsmann, et al.
Nephrology (Carlton, Vic.)|April 23, 2014
The cost-effectiveness of contemporary home haemodialysis modalities compared with facility haemodialysis: a systematic review of full economic evaluationsRachael Walker, Mark R Marshall, Rachael L Morton, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 12, 2016
Supportive Care: Comprehensive Conservative Care in End-Stage Kidney DiseaseFliss E M Murtagh, Aine Burns, Olivier Moranne, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 2, 2010
Patient views about treatment of stage 5 CKD: a qualitative analysis of semistructured interviewsRachael L Morton, Jeannie Devitt, Kirsten Howard, et al.
Applied Health Economics and Health Policy|October 4, 2022
Exploring the Integration of Environmental Impacts in the Cost Analysis of the Pilot MEL-SELF Trial of Patient-Led Melanoma SurveillanceJake T W Williams, Katy J L Bell, Rachael L Morton, et al.
Systematic Reviews|November 10, 2022
Which strategies support the effective use of clinical practice guidelines and clinical quality registry data to inform health service delivery? A systematic reviewKathy Dempsey, Caleb Ferguson, Adam Walczak, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 13, 2026
Methods to include environmental impacts in a cost-effectiveness analysis: a case study of PET/CT surveillance imaging after treatment for stage III melanomaJake T W Williams, Katy J L Bell, Scott McAlister, et al.
Clinical Kidney Journal|June 6, 2022
Trimming the fat: is there a health economic case for the use of new lipid-lowering drugs in chronic kidney disease? A scoping reviewAlexandra Gallagher, Blaise Agresta, Brendan Smyth, et al.
Resuscitation|July 14, 2022
Cost-effectiveness of extracorporeal cardiopulmonary resuscitation for adult out-of-hospital cardiac arrest: A systematic reviewDanielle Addison, Evan Cheng, Paul Forrest, et al.
Pageof 20